Skip to content

Combining Default Choices and a Decision Aid to Improve Tobacco Cessation

Combining Default Choices and a Decision Aid to Improve Tobacco Cessation at 6 Months in Primary Care Patients: a Pragmatic, Cluster-randomized Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04868474
Acronym
FIRST
Enrollment
287
Registered
2021-05-03
Start date
2021-06-15
Completion date
2024-02-29
Last updated
2024-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking Cessation

Keywords

Behavioral economics, Shared decision making, Default choice, Primary care

Brief summary

The FIRST cluster randomized trial will evaluate the effect of 1) a training program encouraging general practitioners to offer smoking cessation treatment as a default choice to all current smokers consulting a general practitioner (GP), and 2) an interactive, electronic decision aid to guide smoking cessation treatment, on the proportion of current smokers seen in primary care who have quit smoking 6 months after a baseline visit to their GP, as compared to enhanced usual care.

Detailed description

Smoking cessation medications are underused in primary care, likely because general practitioners (GP) lack detailed knowledge about prescribing and the fact that smokers seen in primary care must opt-in to treatment. Currently GPs only offer treatment to patients who say they are ready to quit smoking and desire treatment, making the default choice no treatment. Those who are not ready to quit or are hesitant do not discuss quitting or learn about options to help them quit. Further, GPs often lack confidence to discuss smoking cessation medications or do not provide patients with a choice. A decision aid can both help to present quitting with a medication as the default choice and promote shared decision making by allowing patients to see the menu of options available. The current study will combine the use of 'default choices' when approaching smokers and shared decision making with a decision aid for choosing between smoking cessation treatments. The investigators will train GPs to offer smoking cessation as the default choice while involving patients in key decisions using a decision aid. This innovative approach has not been tested in primary care and has the potential to increase the number of current smokers who make a quit attempt with a proven quit aid, thereby increasing the number of patients who quit smoking. The investigators will implement the training as part of the Vivre sans tabac programme for GPs run by the Swiss Medical Association (FMH).

Interventions

BEHAVIORALTraining program and decision aid

1\) a one-time, in-person, 2.5-hour training program encouraging participating GPs to present quitting smoking with a quit aid as the default choice to their eligible patients, and 2) access to an electronic decision aid that presents available quit aids. The 2.5-hour training program consists of: 1.5 hours of didactic teaching, with information about pharmacologic quit aids, electronic cigarettes, presenting quitting as a default choice, the decision aid, and a video of a model consultation. This is followed by 1 hour of role plays to practice presenting quitting as a default choice using the decision aid.

BEHAVIORALRefresher course

A 45-minute refresher training about smoking cessation that does not aim to change GP behaviour. It will include the same information about pharmacologic quit aids and electronic cigarettes.

Sponsors

Tobacco Control Fund Switzerland
CollaboratorOTHER_GOV
Swiss Medical Association (FMH)
CollaboratorOTHER_GOV
Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

The smoking cessation experts administering the trainings will not be blinded. GPs will be not be blinded. GPs in the control group will likely realize their training is shorter, and GPs in the intervention group will realize their training is different from traditional teachings. Patients will be told that the study compares two training programs. To the extent possible, outcome assessors will be blinded to study arm when performing follow-up. The statistician performing the primary outcome analyses will be blinded to group assignments.

Intervention model description

Cluster randomized trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Patient-level inclusion criteria: * Consider the GP they are seeing in consultation to be their primary care doctor * Use tobacco daily (cigarettes, cigars, smokeless tobacco) * ≥18 years of age at the time of inclusion Patient-level

Exclusion criteria

* Consulting for an urgent complaint that precludes even a brief discussion of smoking cessation * Inability to follow the procedures of the study, e.g. unable to read French-language consent materials, severe psychiatric disorders, dementia, etc. * Previous enrolment in a smoking cessation trial \<1 year prior * Current daily user of a pharmacologic smoking cessation aid GP-level inclusion criteria: * GP in private practice in French-speaking Switzerland (Vaud, Geneva, Jura, Neuchâtel, Fribourg or Valais) or metropolitan France * Primarily French-speaking patients with \>80 individual patients seen in a typical month GP-level

Design outcomes

Primary

MeasureTime frameDescription
Smoking cessation6 months follow-up after the baseline visit with a General PractitionerSelf-reported, 7-day point-prevalence smoking abstinence

Secondary

MeasureTime frameDescription
Exhaled Carbon monoxide - patient6 month follow-upChemical confirmation of abstinence among those who report 7-day smoking abstinence
Continuous abstinence - patient6 month follow-upSelf-reported continuous abstinence from the patient's quit date among those who report 7-day smoking abstinence
Smoking cessation - patient3 weeks and 3 months follow-upSelf-reported, 7-day point-prevalence smoking abstinence
Quit attempts - patient6 month follow-upSelf-reported quit attempts (periods of abstinence to try to quit smoking) since the baseline visit
Use of quit aids - patient6 month follow-upSelf-reported use of a quit aid (pharmacologic, electronic cigarette, or additional medical visits to discuss quitting) since the baseline visit
Patient participation - patient3 weeks follow-upPatient-reported participation in discussions about smoking cessation as measured by the CollaboRATE scale

Other

MeasureTime frameDescription
Default choice approach - general practitionerAfter the training program (intention), at the end of patient recruitment, and at 12-months follow-upSelf-reported use of the default choice approach for smoking cessation
Use of decision aid - general practitionerAfter the training program (intention), at the end of patient recruitment, and at 12-months follow-upSelf-reported use of the decision aid (electronic or paper)
Discontinuation rate - GP implementation outcome12 months after trainingNumber of GPs who recruit at least 20 patients / number of GPs randomized
Recruitment rate - patient implementation outcome12 months after trainingNumber of patients who sign consent / number of patients provided information about the trial
Discontinuation rate - patient implementation outcome12 months after trainingNumber of patients who complete 6-month follow-up / number of patients who sign consent
Prescribing quit aids - general practitionerAfter the training program (intention), at the end of patient recruitment, and at 12-months follow-upThe proportion of current smokers who are proposed a smoking cessation aid, as reported by GPs

Countries

France, Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026